Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 2/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20607620 | 1.00 | POLB (0.33) | POLBGAAKMT2ACYP1A2CYP3A4 | |
| SCHEMBL20607623 | 0.92 | POLB (0.31) | POLBGAAKMT2A | |
| SCHEMBL20558340 | 0.90 | CYP1A2 (0.33) | KMT2ACYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL29457643 | 0.90 | CYP1A2 (0.33) | KMT2ACYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL16915402 | 0.89 | L3MBTL1 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL29780129 | 0.89 | L3MBTL1 (0.32) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 | |
| SCHEMBL23489700 | 0.88 | CYP1A2 (0.41) | KMT2ACYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL29780132 | 0.85 | L3MBTL1 (0.30) | POLBGAAKMT2AL3MBTL1 | |
| SCHEMBL20607621 | 0.85 | L3MBTL1 (0.30) | POLBGAAKMT2AL3MBTL1 | |
| SCHEMBL22691623 | 0.85 | CTSA (0.33) | CYP1A2CYP3A4CYP2D6CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4069680-B1 | PROCESS FOR SYNTHESIS OF A 2-(5-ISOXAZOLYL)-PHENOL | FMC CORP (US) | 2026-03-25 | — | — | EP | claimed |
| CN-111574510-B | Pyrimidine as herbicide Oxyphenyl derivatives | FMC 公司 | 2025-03-07 | — | — | CN | claimed |
| CN-114746406-B | Method for synthesizing 2- (5-isoxazolyl) -phenol | FMC公司 | 2024-11-01 | — | — | CN | claimed |
| US-11447476-B2 | Pyrimidinyloxy benzene derivatives as herbicides | FMC CORPORATION (US) | 2022-09-20 | — | — | US | claimed |
| CN-114761384-A | Process for the synthesis of 2-thioalkyl pyrimidines | FMC公司 | 2022-07-15 | — | — | CN | claimed |
| CN-114746406-A | Method for synthesizing 2- (5-isoxazolyl) -phenol | FMC公司 | 2022-07-12 | — | — | CN | claimed |
| CN-114746406-B | Method for synthesizing 2- (5-isoxazolyl) -phenol | FMC公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-114761384-A | Process for the synthesis of 2-thioalkyl pyrimidines | FMC公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114746406-A | Method for synthesizing 2- (5-isoxazolyl) -phenol | FMC公司 | 2022-07-12 | — | — | CN | disclosed |
| EP-3973063-A2 | COMPOSITIONS AND METHODS FOR WEED CONTROL | Syngenta Crop Protection AG (CH) | 2022-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11447476-B2 | Pyrimidinyloxy benzene derivatives as herbicides | DDT, NQO2, CBR3 | POLB 1370/4885GAA 1033/4885KMT2A 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.